A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients
Authors
Keywords
-
Journal
BLOOD
Volume 124, Issue 19, Pages 2921-2929
Publisher
American Society of Hematology
Online
2014-09-19
DOI
10.1182/blood-2014-04-573048
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults >=50 Years of Age
- (2013) R. Chlibek et al. JOURNAL OF INFECTIOUS DISEASES
- A Phase 1/2 Clinical Trial Evaluating Safety and Immunogenicity of a Varicella Zoster Glycoprotein E Subunit Vaccine Candidate in Young and Older Adults
- (2012) Isabel Leroux-Roels et al. JOURNAL OF INFECTIOUS DISEASES
- Non-Hodgkin lymphoma
- (2012) Kate R Shankland et al. LANCET
- Experience with use of Zostavax® in patients with hematologic malignancy and hematopoietic cell transplant recipients
- (2011) Elliot Naidus et al. AMERICAN JOURNAL OF HEMATOLOGY
- Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
- (2011) Nathalie Garçon et al. Expert Review of Vaccines
- Onset and complications of varicella zoster reactivation in the autologous hematopoietic cell transplant population
- (2011) J.E. Rogers et al. Transplant Infectious Disease
- Varicella zoster virus glycoprotein E-specific CD4+ T cells show evidence of recent activation and effector differentiation, consistent with frequent exposure to replicative cycle antigens in healthy immune donors
- (2010) G. N. Malavige et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Advances in the understanding of the pathogenesis and epidemiology of herpes zoster
- (2010) Anne A. Gershon et al. JOURNAL OF CLINICAL VIROLOGY
- Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
- (2009) Marcie Tomblyn et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Vaccination of hematopoietic cell transplant recipients
- (2009) P Ljungman et al. BONE MARROW TRANSPLANTATION
- Stem cell transplantation for multiple myeloma
- (2009) Shaji Kumar CURRENT OPINION IN ONCOLOGY
- Varicella‐Zoster Virus–Specific Immune Responses to Herpes Zoster in Elderly Participants in a Trial of a Clinically Effective Zoster Vaccine
- (2009) Adriana Weinberg et al. JOURNAL OF INFECTIOUS DISEASES
- Functions of the unique N-terminal region of glycoprotein E in the pathogenesis of varicella-zoster virus infection
- (2009) B. Berarducci et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The insulin degrading enzyme binding domain of varicella-zoster virus (VZV) glycoprotein E is important for cell-to-cell spread and VZV infectivity, while a glycoprotein I binding domain is essential for infection
- (2009) Mir A. Ali et al. VIROLOGY
- Treatment of newly diagnosed myeloma
- (2008) A Palumbo et al. LEUKEMIA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started